VSee Health, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
VSee Health, Inc. (VSEE) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-14
- VSee Health, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was -$0.06.
- VSee Health, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$0.12.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month |
|---|---|---|
| 2026-06-30 | -$0.06 10-Q · filed 2026-08-14 | -$0.08 10-Q · filed 2026-08-14 |
| 2025-06-30 | -$0.12 10-Q · filed 2026-08-14 | -$0.34 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |